Drugs / gp100:209-217(210M) Peptide Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01989559 | Oct 2002 → Sep 2013 | cutaneous melanoma | National Cancer Institute (NCI) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | gp100:209-217(210M) Peptide Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01989559 ↗ |
| Modality | Vaccine | “gp100:209-217(210M) peptide vaccine” NCT01989559 ↗ |
| Route | Subcutaneous | “Given SC” NCT01989559 ↗ |